Caroline A. Litchfield's most recent trade in Merck & Co Inc was a trade of 53,735 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on April 29, 2025.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
Merck & Co Inc | Caroline A. Litchfield | EVP & CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Apr 2025 | 53,735 | 53,735 | - | - | Stock Option (Right to Buy) | |
Merck & Co Inc | Caroline A. Litchfield | EVP & CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Apr 2025 | 11,805 | 11,805 | - | - | Restricted Stock Unit | |
Verizon Communications Inc | Caroline A. Litchfield | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Mar 2025 | 4,748 | 5,948 | - | - | Phantom Stock | |
Merck & Co Inc | Caroline A. Litchfield | EVP & CFO | Grant, award, or other acquisition of securities at price $ 97.94 per share. | 27 Jan 2025 | 23,432 | 74,340 (0%) | 0% | 97.9 | 2,294,930 | Common Stock |
Verizon Communications Inc | Caroline A. Litchfield | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Oct 2024 | 1,161 | 1,161 | - | - | Phantom Stock |